Welcome to LookChem.com Sign In|Join Free

CAS

  • or

245421-51-6

Post Buying Request

245421-51-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

245421-51-6 Usage

General Description

"(2,5-dioxopyrrolidin-1-yl) 3-(9H-fluoren-9-ylmethoxycarbonylamino)propanoate" is a chemical compound with a complex molecular structure. It contains a pyrrolidin-1-yl functional group, as well as a fluoren-9-ylmethoxycarbonylamino functional group. (2,5-dioxopyrrolidin-1-yl) 3-(9H-fluoren-9-ylmethoxycarbonylamino)propanoate is a propanoate derivative, and its chemical properties make it suitable for various applications in organic synthesis and pharmaceutical research. The presence of the pyrrolidin-1-yl and fluoren-9-yl groups suggests that it may have potential as a building block for the synthesis of more complex organic molecules, as well as potential biological activity due to the fluoren-9-yl group. Further research and testing would be needed to fully understand the potential uses and properties of this compound.

Check Digit Verification of cas no

The CAS Registry Mumber 245421-51-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,5,4,2 and 1 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 245421-51:
(8*2)+(7*4)+(6*5)+(5*4)+(4*2)+(3*1)+(2*5)+(1*1)=116
116 % 10 = 6
So 245421-51-6 is a valid CAS Registry Number.

245421-51-6Downstream Products

245421-51-6Relevant articles and documents

Optimization of axial ligands to promote the photoactivation of BODIPY-conjugated platinum(iv) anticancer prodrugs

Gunawan, Yuliana F.,Liu, Gongyuan,Tse, Man-Kit,Yao, Houzong,Zhu, Guangyu

, p. 13737 - 13747 (2021/10/19)

Carboplatin-based platinum(iv) prodrugs containing axial carboxylates are relatively resistant to reduction to release active platinum(ii) species and kill cancer cells. To facilitate the activation process, a boron dipyrromethene (BODIPY) ligand has been utilized as a photoabsorber at the axial position to photoactivate carboplatin-based platinum(iv) complexes. However, the influence of the axial ligands on the photoactivation rate of the platinum center and the subsequent biological activity are still unknown. In this study, we report the design and synthesis of a series of carboplatin-based photoactivable platinum(iv) prodrugs containing BODIPY axial ligands with different lengths. The resulting BODIPY-conjugated platinum(iv) prodrugsOH2C-OH8Cbearing hydroxido ligands at the opposite axial position are slightly less stable in the dark than the corresponding prodrugsAC2C-AC8Ccontaining acetato ligands. The prodrugsOH3C-OH8Ccan be photoactivated under irradiation in eight minutes, and the photoactivation rate is further improved in prodrugsAC3C-AC8Cwhere only twenty seconds are needed. Moreover, the prodrugAC3C, in which the linker between the BODIPY photoabsorber and the platinum center has an appropriate length, is photoactivated the quickest among the acetylated prodrugsAC2C-AC8C. The high cellular accumulation may contribute more to the moderate photocytotoxicity of these prodrugs. Our research highlights the way to promote the photoactivation of BODIPY-conjugated platinum(iv) anticancer prodrugs by optimization of axial ligands and may contribute to the future rational design of photoactivable platinum-based complexes.

SPLICEOSTATIN ANALOGS

-

Page/Page column 171; 172, (2014/05/24)

The present invention is directed to novel cytotoxic spliceostatin analogs (I) and derivatives, to antibody drug conjugates thereof, and to methods for using the same to treat medical conditions including cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 245421-51-6